Tetraphase Pharmaceuticals, Inc.
TTPH
TTPH was delisted on the 28th of July, 2020.
101 hedge funds and large institutions have $108M invested in Tetraphase Pharmaceuticals, Inc. in 2016 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 36 increasing their positions, 23 reducing their positions, and 20 closing their positions.
123% more call options, than puts
Call options by funds: $2.51M | Put options by funds: $1.13M
57% more repeat investments, than reductions
Existing positions increased: 36 | Existing positions reduced: 23
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
4% less funds holding
Funds holding: 105 → 101 (-4)
10% less first-time investments, than exits
New positions opened: 18 | Existing positions closed: 20
59% less capital invested
Capital invested by funds: $264M → $108M (-$156M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
+$8.56M |
| 2 |
NI
Numeric Investors
Boston,
Massachusetts
|
+$4.46M |
| 3 |
Renaissance Technologies
New York
|
+$2.92M |
| 4 |
CC
Clearline Capital
New York
|
+$2.09M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$1.05M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$18.8M |
| 2 |
BB
BB Biotech
Schaffhausen,
Switzerland
|
-$3.67M |
| 3 |
ARTA
A.R.T. Advisors
New York
|
-$3.54M |
| 4 |
State Street
Boston,
Massachusetts
|
-$3.38M |
| 5 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
-$3.06M |
TTPH Hedge Fund Activity: Q1 2016 in Review
101 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Tetraphase Pharmaceuticals, Inc. (TTPH) for Q1 2016, worth a combined $108M — down 59% from $264M a quarter earlier.
Sellers outnumbered buyers: 20 funds closed out of TTPH and 18 opened new positions — a net loss of 2 holders — while 23 trimmed existing stakes and 36 added.
The largest buyer was Great Point Partners, adding an estimated $8.56M. The largest seller was Wellington Management Group, cutting an estimated $18.8M.
- 101 institutional investors held Tetraphase Pharmaceuticals, Inc. (TTPH) as of Q1 2016, down from 105 in Q4 2015.
- Funds reported $108M of Tetraphase Pharmaceuticals, Inc. stock for Q1 2016, down 59% quarter-over-quarter.
- 18 funds opened new Tetraphase Pharmaceuticals, Inc. positions in Q1 2016 and 20 closed out, a net change of -2 holders.
- The largest Tetraphase Pharmaceuticals, Inc. buyer in Q1 2016 was Great Point Partners, an estimated $8.56M added.
- The largest Tetraphase Pharmaceuticals, Inc. seller in Q1 2016 was Wellington Management Group, an estimated $18.8M sold.
Based on aggregated 13F filings for Q1 2016.